NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

遺傳基因輸送技術市場 - 市場佔有率,市場規模,趨勢,產業分析:2021年∼2028年

Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode (Biological, Chemical, Physical); By Application (Gene Therapy, Cell Therapy, Vaccines, Research); By Method; By Regions; Segment Forecast, 2021 -2028

出版商 Polaris Market Research 商品編碼 1004391
出版日期 內容資訊 英文 127 Pages
商品交期: 最快1-2個工作天內
價格
遺傳基因輸送技術市場 - 市場佔有率,市場規模,趨勢,產業分析:2021年∼2028年 Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode (Biological, Chemical, Physical); By Application (Gene Therapy, Cell Therapy, Vaccines, Research); By Method; By Regions; Segment Forecast, 2021 -2028
出版日期: 2021年04月01日內容資訊: 英文 127 Pages
簡介

全球遺傳基因輸送技術的市場規模,預計至2028年達到78億6,000萬美元。2020年,佔基因治療市場區隔最大的佔有率。全球接受了基因治療,此後臨床研究活動增加,促進這個市場區隔的市場成長。

本報告提供全球遺傳基因輸送技術市場相關調查分析,有關目前市場動態的詳細的考察,未來市場成長相關分析相關的系統性資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 遺傳基因輸送技術市場考察

  • 遺傳基因輸送技術 - 產業的概述
  • 遺傳基因輸送技術市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • 大環境分析
  • 遺傳基因輸送技術市場產業趨勢

第5章 遺傳基因輸送技術市場評估:各模式

  • 主要調查結果
  • 簡介
  • 生物學的技術
  • 化學的技術
  • 物理的技術

第6章 全球遺傳基因輸送技術市場:各用途

  • 主要調查結果
  • 簡介
  • 基因治療
  • 細胞療法
  • 疫苗
  • 研究

第7章 遺傳基因輸送技術市場評估:各手法

  • 主要調查結果
  • 簡介
  • 生物外
  • 生物內
  • 試管內

第8章 遺傳基因輸送技術市場評估:各地區

  • 主要調查結果
  • 簡介
  • 遺傳基因輸送技術市場 - 北美
  • 遺傳基因輸送技術市場 - 歐洲
  • 遺傳基因輸送技術市場 - 亞太地區
  • 遺傳基因輸送技術市場 - 中東、非洲
  • 遺傳基因輸送技術市場 - 南美

第9章 競爭情形

  • 擴張與收購分析
  • 夥伴關係/聯盟/契約/公開

第10章 企業簡介

  • Thermo Fisher Scientific, Inc.
  • Horizon Discovery Group Co.
  • OriGene Technologies, Inc.
  • Oxford Biomedica
  • SignaGen Laboratories
  • Takara Bio Inc.
  • System Biosciences llc
  • Promega Corporation
  • F. Hoffmann - La Roche AG
  • QIAGEN
  • Vectalys
  • Bio - Rad Laboratories, Inc.
  • Catalent Inc.
  • Agilent Technologies
  • Sirion - Biotech GmbH
目錄
Product Code: PM1857

The global gene delivery technologies market size is expected to reach USD 7.86 billion by 2028 according to a new study by Polaris Market research. The report "Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode (Biological [Adenovirus, Retrovirus, AAV, Lentivirus, Other Viruses, Non-viral], Chemical, Physical); By Application (Gene Therapy, Cell Therapy, Vaccines, Research); By Method; By Regions; Segment Forecast, 2021 -2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

In 2020, the gene therapy market segment accounted for the largest share. Worldwide acceptance of gene therapies and subsequent rise in clinical research activities have boosted the segment's market growth. Moreover, rising approvals for gene therapy products and services also accelerated the gene delivery technologies market growth prospects.

The vaccine market segment is projected to witness a lucrative growth rate over the gene delivery technologies study period. This is primarily due to the ability of such vaccines for different treatment approaches for both preventive and therapeutic areas. They have the potential to activate potent humoral responses. This has boosted the demand for gene editing tools for vaccine development.

The gene delivery technologies market segment is anticipated to benefit from a sudden rise in COVID-19 cases. As of August 2020, more than 25 research groups have been working for vector-based vaccines to contain COVID-19 infection. Similarly, approximately 20 research teams are exploring approaches to develop nucleic acid vaccines.

Market participants in gene delivery technologies industry include Horizon Discovery Group Co., QIAGEN, Oxford Biomedica, SignaGen Laboratories, Hoffmann-La Roche AG, Vectalys, Sirion-Biotech GmbH, Takara Bio Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., OriGene Technologies, Inc., System Biosciences, Promega Corporation, and Catalent Inc.

The market players operating in the gene delivery technologies industry are focusing on mergers and acquisitions to stay competitive in the market. In line with this, in May 2020, Merck, completed the acquisition of Themis, an immune-modulation therapy to expand its vaccine development program for the surging COVID-19 numbers. Similarly, earlier, in May 2019, already acquired Brammer Bio, a U.S.-based company engaged in the development of viral vectors to be used in gene therapies.

Polaris Market Research has segmented the gene delivery technologies market report on the basis of mode, application, method, and region:

Gene Delivery Technologies, Mode Outlook (Revenue - USD Million, 2016 - 2028)

Biological

Adenovirus

Retrovirus

AAV

Lentivirus

Other viruses

Non-viral

Chemical

Physical

Gene Delivery Technologies, Application Outlook (Revenue - USD Million, 2016 - 2028)

Gene Therapy

Cell Therapy

Vaccines

Research

Gene Delivery Technologies, Method Outlook (Revenue - USD Million, 2016 - 2028)

Ex vivo

In vivo

In vitro

Gene Delivery Technologies, by Regional Outlook (Revenue - USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Gene Delivery Technologies Market Insights

  • 4.1. Gene Delivery Technologies - Industry snapshot
  • 4.2. Gene Delivery Technologies Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Technogical advancements in delivery systems
      • 4.2.1.2. Ageing population across the globe
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Product recalls
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Gene Delivery Technologies Market Industry trends

5. Gene Delivery Technologies Market Assessment by Mode

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • 5.3. Biological
    • 5.3.1. Global Gene Delivery Technologies Market, by Biological, by Region, 2016 - 2028 (USD Million)
    • 5.3.2. Adenovirus
      • 5.3.2.1. Global Adenovirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
    • 5.3.3. Retrovirus
      • 5.3.3.1. Global Retrovirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
    • 5.3.4. AAV
      • 5.3.4.1. Global AAV Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
    • 5.3.5. Lentivirus
      • 5.3.5.1. Global Lentivirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
    • 5.3.6. Other Viruses
      • 5.3.6.1. Global Other Viruses Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
    • 5.3.7. Non-viral
      • 5.3.7.1. Global Non-viral Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
  • 5.4. Chemical
    • 5.4.1. Global Gene Delivery Technologies Market, by Chemical, by Region, 2016 - 2028 (USD Million)
  • 5.5. Physical
    • 5.5.1. Global Gene Delivery Technologies Market, by Physical, by Region, 2016 - 2028 (USD Million)

6. Global Gene Delivery Technologies Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • 6.3. Gene Therapy
    • 6.3.1. Global Gene Delivery Technologies Market, by Gene Therapy, By Region, 2016 - 2028 (USD Million)
  • 6.4. Cell Therapy
    • 6.4.1. Global Gene Delivery Technologies Market, by Cell Therapy, by Region, 2016 - 2028 (USD Million)
  • 6.5. Vaccines
    • 6.5.1. Global Gene Delivery Technologies Market, by Vaccines, by Region, 2016 - 2028 (USD Million)
  • 6.6. Research
    • 6.6.1. Global Gene Delivery Technologies Market, by Research, by Region, 2016 - 2028 (USD Million)

7. Gene Delivery Technologies Market Assessment by Method

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • 7.3. Ex vivo
    • 7.3.1. Global Gene Delivery Technologies Market, by Ex vivo, by Region, 2016 - 2028 (USD Million)
  • 7.4. In vivo
    • 7.4.1. Global Gene Delivery Technologies Market, by In vivo, by Region, 2016 - 2028 (USD Million)
  • 7.5. In vitro
    • 7.5.1. Global Gene Delivery Technologies Market, by In vitro, by Region, 2016 - 2028 (USD Million)

8. Gene Delivery Technologies Market Assessment by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 8.3. Gene Delivery Technologies Market - North America
    • 8.3.1. North America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
    • 8.3.2. North America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
    • 8.3.3. North America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.3.4. Gene Delivery Technologies Market - U.S.
      • 8.3.4.1. U.S.: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.3.4.2. U.S.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.3.4.3. U.S.: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.3.5. Gene Delivery Technologies Market - Canada
      • 8.3.5.1. Canada: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.3.5.2. Canada.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.3.5.3. Canada: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • 8.4. Gene Delivery Technologies Market - Europe
    • 8.4.1. Europe: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
    • 8.4.2. Europe.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
    • 8.4.3. Europe: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.4. Gene Delivery Technologies Market - UK
      • 8.4.4.1. UK: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.4.2. UK.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.4.3. UK: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.5. Gene Delivery Technologies Market - France
      • 8.4.5.1. France: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.5.2. France.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.5.3. France: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.6. Gene Delivery Technologies Market - Germany
      • 8.4.6.1. Germany: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.6.2. Germany.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.6.3. Germany: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.7. Gene Delivery Technologies Market - Italy
      • 8.4.7.1. Italy: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.7.2. Italy.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.7.3. Italy: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.8. Gene Delivery Technologies Market - Spain
      • 8.4.8.1. Spain: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.8.2. Spain.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.8.3. Spain: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.9. Gene Delivery Technologies Market - Netherlands
      • 8.4.9.1. Netherlands: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.9.2. Netherlands.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.9.3. Netherlands: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.4.10. Gene Delivery Technologies Market - Austria
      • 8.4.10.1. Austria: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.4.10.2. Austria.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.4.10.3. Austria: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • 8.5. Gene Delivery Technologies Market - Asia-Pacific
    • 8.5.1. Asia Pacific: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
    • 8.5.2. Asia Pacific.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
    • 8.5.3. Asia Pacific: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.4. Gene Delivery Technologies Market - China
      • 8.5.4.1. China: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.4.2. China.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.4.3. China: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.5. Gene Delivery Technologies Market - India
      • 8.5.5.1. India: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.5.2. India.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.5.3. India: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.6. Gene Delivery Technologies Market - Malaysia
      • 8.5.6.1. Malaysia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.6.2. Malaysia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.6.3. Malaysia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.7. Gene Delivery Technologies Market - Japan
      • 8.5.7.1. Japan: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.7.2. Japan.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.7.3. Japan: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.8. Gene Delivery Technologies Market - Indonesia
      • 8.5.8.1. Indonesia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.8.2. Indonesia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.8.3. Indonesia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.5.9. Gene Delivery Technologies Market - South Korea
      • 8.5.9.1. South Korea: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.5.9.2. South Korea.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.5.9.3. South Korea: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • 8.6. Gene Delivery Technologies Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
    • 8.6.2. Middle East & Africa.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
    • 8.6.3. Middle East & Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.6.4. Gene Delivery Technologies Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.6.4.3. Saudi Arabia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.6.5. Gene Delivery Technologies Market - UAE
      • 8.6.5.1. UAE: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.6.5.2. UAE.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.6.5.3. UAE: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.6.6. Gene Delivery Technologies Market - Israel
      • 8.6.6.1. Israel: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.6.6.2. Israel.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.6.6.3. Israel: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.6.7. Gene Delivery Technologies Market - South Africa
      • 8.6.7.1. South Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.6.7.2. South Africa.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.6.7.3. South Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • 8.7. Gene Delivery Technologies Market - Latin America
    • 8.7.1. Latin America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
    • 8.7.2. Latin America.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
    • 8.7.3. Latin America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.7.4. Gene Delivery Technologies Market - Mexico
      • 8.7.4.1. Mexico: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.7.4.2. Mexico.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.7.4.3. Mexico: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
    • 8.7.5. Gene Delivery Technologies Market - Brazil
      • 8.7.5.1. Brazil: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.7.5.2. Brazil.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.7.5.3. Brazil: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)'
    • 8.7.6. Gene Delivery Technologies Market - Argentina
      • 8.7.6.1. Argentina: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
      • 8.7.6.2. Argentina.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
      • 8.7.6.3. Argentina: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisition
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Thermo Fisher Scientific, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product & Services Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Horizon Discovery Group Co.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product & Services Benchmarking
    • 10.2.4. Recent Development
  • 10.3. OriGene Technologies, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product & Services Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Oxford Biomedica
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product & Services Benchmarking
    • 10.4.4. Recent Development
  • 10.5. SignaGen Laboratories
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product & Services Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takara Bio Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product & Services Benchmarking
    • 10.6.4. Recent Development
  • 10.7. System Biosciences llc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product & Services Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Promega Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product & Services Benchmarking
    • 10.8.4. Recent Development
  • 10.9. F. Hoffmann - La Roche AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product & Services Benchmarking
    • 10.9.4. Recent Development
  • 10.10. QIAGEN
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product & Services Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Vectalys
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product & Services Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Bio - Rad Laboratories, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product & Services Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Catalent Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product & Services Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Agilent Technologies
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product & Services Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sirion - Biotech GmbH
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product & Services Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 2 Global Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 3 Global Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 4 Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 5 North America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 6 North America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 7 North America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 8 U.S.: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 9 U.S.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 10 U.S.: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 11 Canada: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 12 Canada: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 13 Canada: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 14 Europe: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 15 Europe: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 16 Europe: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 17 UK: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 18 UK: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 19 UK: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 20 France: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 21 France: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 22 France: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 23 Germany: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 24 Germany: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 25 Germany: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 26 Italy: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 27 Italy: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 28 Italy: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 29 Spain: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 30 Spain: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 31 Spain: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 32 Netherlands: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 33 Netherlands: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 34 Netherlands: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 35 Austria: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 36 Austria: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 37 Austria: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 38 Asia Pacific: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 39 Asia Pacific: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 40 Asia Pacific: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 41 China: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 42 China: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 43 China: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 44 India: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 45 India: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 46 India: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 47 Malaysia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 48 Malaysia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 49 Malaysia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 50 Japan: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 51 Japan: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 52 Japan: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 53 Indonesia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 54 Indonesia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 55 Indonesia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 56 South Korea: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 57 South Korea: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 58 South Korea: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 59 Middle East & Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 60 Middle East & Africa: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 61 Middle East & Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 62 Saudi Arabia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 63 Saudi Arabia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 64 Saudi Arabia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 65 UAE: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 66 UAE: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 67 UAE: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 68 Israel: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 69 Israel: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 70 Israel: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 71 South Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 72 South Africa: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 73 South Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 74 Latin America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 75 Latin America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 76 Latin America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 77 Mexico: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 78 Mexico: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 79 Mexico: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 80 Brazil: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 81 Brazil: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 82 Brazil: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
  • Table 83 Argentina: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
  • Table 84 Argentina: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
  • Table 85 Argentina: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)

List of Figures

Figure 1. Market Highlights (2020, Revenue)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top Down & Bottom Up Approach

Figure 4. Market by Geography

Figure 6. Porter's Five Forces

Figure 7. Market by Mode

Figure 8. Global Gene Delivery Technologies Market, By Mode, 2020 & 2028 (USD Million)

Figure 9. Market by Application

Figure 10. Global Gene Delivery Technologies Market, By Application, 2020 & 2028 (USD Million)

Figure 11. Market by Method

Figure 12. Global Gene Delivery Technologies Market, By Method, 2020 & 2028 (USD Million)

Figure 13. Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)

Figure 14. Strategic Analysis - Gene Delivery Technologies Market